To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health ...
12/12/18
To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health Xconomy
Synergy Pharmaceuticals has spent years looking for a buyer. The developer of a struggling drug for two types of chronic constipation finally has.
[more]